Ezintsha, a research group at Wits University that investigates better options for first-line antiretroviral treatment (ART) regimens for people with HIV, today published its 96-week outcomes in the prestigious Lancet HIV ...
Oct 1, 2020
0
4
With a significantly costlier medication for HIV preexposure prophylaxis (PrEP) approved in 2019, a new study examined reasons patients switched to the new drug. Study results indicate that a minority of those who switched ...
Aug 5, 2021
0
2
In October 2019, the U.S. Food and Drug Administration approved a second medication for use as HIV preexposure prophylaxis, also known as PrEP, sparking controversy about which drug should be prescribed. Gilead Sciences, ...
Jan 13, 2020
0
12
Swiss pharmaceuticals giant Roche said it had received the necessary approval from competition authorities to acquire US gene-therapy group Spark, after the two companies reached a multibillion-dollar deal earlier this year.
Dec 17, 2019
0
6
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
4
US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.
May 16, 2023
0
33
Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.
Mar 13, 2012
0
0
People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers ...
Jul 10, 2012
0
0
"Pharma bro" Martin Shkreli may have violated a judge's order banning him from being involved in the pharmaceutical industry, the U.S. Federal Trade Commission announced Friday.
Jan 23, 2023
0
1
(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.
Sep 4, 2012
0
1
